Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy

per Chrétien, Sebastian, Zerdes, Ioannis, Bergh, Jonas, Matikas, Alexios, Foukakis, Theodoros
Publicat a Cancers (Basel) (2019)

Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations

per Zerdes, Ioannis, Matikas, Alexios, Bergh, Jonas, Rassidakis, George Z., Foukakis, Theodoros
Publicat a Oncogene (2018)

Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes

per Vardaki, Ioulia, Ceder, Sophia, Rutishauser, Dorothea, Baltatzis, George, Foukakis, Theodoros, Panaretakis, Theocharis
Publicat a Oncotarget (2016)

Intrinsic subtypes and genomic signatures of primary breast cancer and prognosis after systemic relapse

per Falato, Claudette, Tobin, Nicholas P., Lorent, Julie, Lindström, Linda S., Bergh, Jonas, Foukakis, Theodoros
Publicat a Mol Oncol (2015)

Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer Trial

per Mijwel, Sara, Bolam, Kate A., Gerrevall, Jacob, Foukakis, Theodoros, Wengström, Yvonne, Rundqvist, Helene
Publicat a Oncologist (2019)

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies

per Milosevic, Jelena, Klinge, Johanna, Borg, Anna-Lena, Foukakis, Theodoros, Bergh, Jonas, Tobin, Nicholas P
Publicat 2013

Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide

per von Stedingk, Hans, Xie, Hanjing, Hatschek, Thomas, Foukakis, Theodoros, Rydén, Andreas, Bergh, Jonas, Rydberg, Per
Publicat 2014

Chemotherapy use near the end-of-life in patients with metastatic breast cancer

per Edman Kessler, Luisa, Sigfridsson, Johnny, Hatzidaki, Dora, Bergh, Jonas, Foukakis, Theodoros, Georgoulias, Vasilios, Matikas, Alexios
Publicat a Breast Cancer Res Treat (2020)

Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early brea...

per Brandberg, Yvonne, Johansson, Hemming, Hellström, Mats, Gnant, Michael, Möbus, Volker, Greil, Richard, Foukakis, Theodoros, Bergh, Jonas
Publicat a Breast Cancer Res Treat (2020)

Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer

per Foukakis, Theodoros, Lövrot, John, Sandqvist, Patricia, Xie, Hanjing, Lindström, Linda S., Giorgetti, Carla, Jacobsson, Hans, Hedayati, Elham, Bergh, Jonas
Publicat a Mol Oncol (2015)

Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single Cell Sequencing

per Kim, Charissa, Gao, Ruli, Sei, Emi, Brandt, Rachel, Hartman, Johan, Hatschek, Thomas, Crosetto, Nicola, Foukakis, Theodoros, Navin, Nicholas
Publicat a Cell (2018)

External Evaluation of 3 Commercial Artificial Intelligence Algorithms for Independent Assessment of Screening Mammograms

per Salim, Mattie, Wåhlin, Erik, Dembrower, Karin, Azavedo, Edward, Foukakis, Theodoros, Liu, Yue, Smith, Kevin, Eklund, Martin, Strand, Fredrik
Publicat a JAMA Oncol (2020)

PD-1 protein and gene expression as prognostic factors in early breast cancer

per Matikas, Alexios, Zerdes, Ioannis, Lövrot, John, Sifakis, Emmanouil, Richard, Francois, Sotiriou, Christos, Rassidakis, Georgios, Bergh, Jonas, Valachis, Antonis, Foukakis, Theodoros
Publicat a ESMO Open (2020)

Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen recep...

per Zerdes, Ioannis, Sifakis, Emmanouil G., Matikas, Alexios, Chrétien, Sebastian, Tobin, Nicholas P., Hartman, Johan, Rassidakis, George Z., Bergh, Jonas, Foukakis, Theodoros
Publicat a Mol Oncol (2020)

Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancer

per Gao, Ruli, Kim, Charissa, Sei, Emi, Foukakis, Theodoros, Crosetto, Nicola, Chan, Leong-Keat, Srinivasan, Maithreyan, Zhang, Hong, Meric-Bernstam, Funda, Navin, Nicholas
Publicat a Nat Commun (2017)

Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer

per Matikas, Alexios, Lövrot, John, Ramberg, Anna, Eriksson, Margareta, Lindsten, Therese, Lekberg, Tobias, Hedenfalk, Ingrid, Loman, Niklas, Bergh, Jonas, Hatschek, Thomas, Erlandsson, Ann, Foukakis, Theodoros
Publicat a Oncoimmunology (2018)

Proteomic profiling of follicular and papillary thyroid tumors

per Sofiadis, Anastasios, Becker, Susanne, Hellman, Ulf, Hultin-Rosenberg, Lina, Dinets, Andrii, Hulchiy, Mykola, Zedenius, Jan, Wallin, Göran, Foukakis, Theodoros, Höög, Anders, Auer, Gert, Lehtiö, Janne, Larsson, Catharina
Publicat 2012

Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts

per Lundberg, Arian, Lindström, Linda S., Harrell, J. Chuck, Falato, Claudette, Carlson, Joseph W., Wright, Paul K., Foukakis, Theodoros, Perou, Charles M., Czene, Kamila, Bergh, Jonas, Tobin, Nicholas P.
Publicat a Clin Cancer Res (2017)

The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours

per Lundberg, Arian, Lindström, Linda S., Li, Jingmei, Harrell, J. Chuck, Darai-Ramqvist, Eva, Sifakis, Emmanouil G., Foukakis, Theodoros, Perou, Charles M., Czene, Kamila, Bergh, Jonas, Tobin, Nicholas P.
Publicat a Breast Cancer Res (2019)

Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation

per Wang, Kang, Li, Zhuyue, Chen, Xingxing, Zhang, Jianjun, Xiong, Yongfu, Zhong, Guochao, Shi, Yang, Li, Qing, Zhang, Xiang, Li, Hongyuan, Xiang, Tingxiu, Foukakis, Theodoros, Radivoyevitch, Tomas, Ren, Guosheng
Publicat a NPJ Breast Cancer (2021)